Navigation Links
Keryx Biopharmaceuticals Receives Nasdaq Notification
Date:4/25/2008

ese requirements. Under the rules of the Nasdaq Capital Market, the Company would have an additional 180-calendar day compliance period through April 17, 2009 to comply with the $1.00 minimum closing bid price requirement on the Nasdaq Capital Market, provided the Company otherwise meets the continued listing requirements for the Nasdaq Capital Market.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that modulates Akt, a protein in the body associated with tumor survival and growth. KRX-0401 also modulates a number of other key signal transduction pathways, including the JNK and MAPK pathways, which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 2 clinical development for multiple tumor types. The Company also has an in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

Cautionary Statement

Some of the statements included in this press release may be forward- looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
2. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
3. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
4. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
6. Keryx Biopharmaceuticals Announces Additions to Management Team
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
10. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
11. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  Mike Patterson, ... of $1.6 million in Series Seed B funding ... chemical sensors for the life science, defense, intelligence, ... Capital Partners led the round and was joined ... Angels.  Said Patterson , "This round of ...
(Date:7/19/2014)... July 20, 2014 United States ... , GlobalDatas new report, "United States Non-Vascular Stents ... on the United States Non-Vascular Stents market. The ... volume (in units) and average prices (in US ... Biliary Stents and Metal Biliary Stents (Metal Non-Covered ...
(Date:7/18/2014)... (PRWEB) July 18, 2014 Reflecting the importance ... past ten years, Connie Rankin, the founder and president ... affiliate, recently introduced a fresh new approach to the ... for a Broker to influence the success of his or ... years. CRES was one of the first in this market ...
(Date:7/18/2014)... , July 18, 2014 The International Wheat ... journal Science a draft sequence of the bread wheat ... structure, organization, and evolution of the large, complex genome ... The genetic blueprint is an invaluable resource to ... they have at their disposal a set of tools ...
Breaking Biology Technology:Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4LEED AP Certified ITRA Global / Customized Real Estate Services Introduces New Approach to Its Branding 2Genetic Blueprint of Bread Wheat Genome Unveiled 2Genetic Blueprint of Bread Wheat Genome Unveiled 3
... HAIKOU CITY, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China,Pharma Holdings, ... company which develops, manufactures, and markets,its products in China, ... at two upcoming U.S. conferences., -- Rodman ... Growth Track) will be held November ...
... success at Berlin conference, RALEIGH, N.C., Nov. ... announces it will present during the,Partnerships in Clinical ... Berlin,Germany. PRA,s Christian Tucat, Senior Vice President of ... the evolution of CRO,partnerships?" at 4PM on Wednesday, ...
... Wall St. Network,s 3-Minute,Press Show is a daily ... interviews with public company executives on their,company and most ... provide viewers with insight into a company,s,latest news, and ... Shows air Monday through Friday at: ...
Cached Biology Technology:China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences 2China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences 3PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress 2[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO 2
(Date:7/21/2014)... How many times do we see an innovation and ... Our minds start turning towards thoughts of our own ... inspiration is the concept behind the International Space Station ... scientists see what their colleagues have going on in ... , "Our goal is to encourage investigators to propose ...
(Date:7/21/2014)... word "dog" have meaning? If you say "dog" to ... Kansas State University philosopher Elliott Wagner aims to address ... focuses on long-standing philosophical questions about semantic meaning. Wagner, ... a mathematician are collaborating to use game theory to ... I order a cappuccino at a coffee shop, I ...
(Date:7/21/2014)... from the strength of immune response, rather than with ... attacking the virus, might be a better way to ... of Washington, Seattle. She and her collaborators have now ... the H7N9 influenza, and their work has already led ... virulent strain. The research is published ahead of print ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2Potential new flu drugs target immune response, not virus 2
... Marine Sanctuary and the Government of Bermuda have pledged ... the endangered North Atlantic humpback whale population. ... programs that could lead to better managing and protecting ... of Maine to the Caribbean Sea. Like the ...
... Clark & Nigel Barker ( Rhodes University ... Charles Stirton & Muthama Muasya ( University of Cape Town ... is the latest endemic species from the Sneeuberg Centre ... poorly explored Great Escarpment in South Africa. The study was ...
... MADISON For thousands of years, bakers and brewers have ... dioxide. Yet, University of Wisconsin-Madison researchers eager to harness this ... churning through sugars, these budding microbes can be picky eaters. ... of the National Academy of Sciences , a Great Lakes ...
Cached Biology News:NOAA, Bermuda partner to protect humpback whales in the North Atlantic 2Pearl-flowered legume a surprise new find in the Cape Snowy Mountains, South Africa 2 Novel gene increases yeast's appetite for plant sugars 2
...
... TOPO PCR Cloning Kit offers the ... (>=95%) cloning of blunt-end PCR products ... kit includes the linearized and topoisomerase ... bench-top ligations without ligase (1). The ...
Carp Vitellogenin ELISA System, 96 wells. ELISARange: 5.0-225 ng/ml.Sensitivity: 5.0 ng/ml.Sample volume: 100 ul.Suitable for use with Carp plasma samples.3-h protocol.Store at 2-8 C. Category: Drug ...
... provide rapid and efficient removal of short ... salts from PCR products (Figure 1). The ... Binding Buffer options for fragments >100 bp ... in either single column or 96-well plate ...
Biology Products: